16
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Effects of Neuropeptide Y on the in vitro Release of Gonadotropin-Releasing Hormone, Luteinizing Hormone, and Beta-Endorphin and Pituitary Responsiveness to Gonadotropin-Releasing Hormone in Female Macaques

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The objectives of these studies were to examine the release of gonadotropin-releasing hormone (GnRH) and β-endorphin-like activity (β-EP) from macaque hypothalami, and the release of luteinizing hormone (LH) and GnRH-induced LH from macaque anterior pituitaries in response to neuropeptide Y (NPY) treatment. Anterior hypothalamic (AH) and mediobasal hypothalamic (MBH) blocks of tissues and the adenohypophysis were bisected along the midline into two equal-sized fragments. Fragments were superfused with medium for 3 h, followed by 3 h of either NPY (80 nM) or medium alone. In a separate experiment, adenohypophyseal (AP) fragments were superfused in accordance with the same protocol (3 h medium – 3 h NPY or medium) except that exogenous GnRH (352 n M) was added for 30 min at the beginning of hour 3 and again at the beginning of hour 6. Immunoactive GnRH, β-EP, and LH levels were measured in superfusate samples (400 µl) collected at 10-min intervals. GnRH levels rose within 20–30 min of initiation of NPY treatment, and elevated GnRH release was sustained for the duration of NPY exposure of both AH and MBH fragments from ovarian intact (INT) rhesus ( Macaca mulatta; n = 8; p < 0.05) or Japanese ( Macaca fascicularis; n = 4; p < 0.01) macaques. NPY treatment had no effect on either AH or MBH fragments isolated from ovariectomized (OVX) rhesus macaques (n = 4 for AH, and n = 5 for MBH). In AP fragments isolated from INT rhesus macaques (n = 8), NPY stimulated LH release within 1 h of treatment (p < 0.05), whereas NPY had no effect on pituitaries from OVX animals (n = 4). Exogenous GnRH stimulated LH release within 20 min; however, the administration of NPY did not alter the responsiveness of Japanese macaque pituitaries to GnRH (p > 0.05; n = 7). NPY treatment had no effect on β-EP release from AH, MBH, and AP tissues of either INT or OVX rhesus macaques. These findings suggest that (1) the stimulatory action of NPY on GnRH release in macaque hypothalami and LH release in macaque anterior pituitaries requires functioning ovaries; (2) NPY does not enhance the sensitivity of macaque gonadotropes to GnRH stimulation, and (3) the mechanism of stimulatory NPY action may not involve the neuronal release of β-EP.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1991
          1991
          04 April 2008
          : 53
          : 4
          : 396-403
          Affiliations
          aReproductive Biology and Behavior, Oregon Regional Primate Research Center, Beaverton, Oreg.; Departments of bPhysiology, and cCell Biology and Anatomy, Oregon Health Sciences University, Portland, Oreg., USA
          Article
          125747 Neuroendocrinology 1991;53:396–403
          10.1159/000125747
          2046872
          8337966b-9a37-4155-941d-a8f4eb636a46
          © 1991 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 16 July 1990
          : 27 September 1990
          Page count
          Pages: 8
          Categories
          Original Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Luteinizing hormone,Hypothalamus,Primates,Neuropeptide Y,Gonadotropin-releasing hormone,Opioid peptides

          Comments

          Comment on this article